Answers are grounded in this paper and cite their sources.
Introduction . Myeloproliferative neoplasms (MPNs) are a rare but significant cause of strokes. Aim . To describe risk factors for stroke development, as well as prevention strategies based on available literature data on patients with MPN. Main findings . Online databases (PubMed, E-Library) were searched for studies on cerebral thrombotic complications in the setting of myeloproliferative disorders. Induction of specific cytoreductive treatment with low doses of acetylsalicylic ac id should be considered as a mandatory component of secondary prevention of noncardioembolic stroke.
No takes yet. Share an insight, caveat, or question.
Kuznetsova et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: